Laurus Labs Stock

Laurus Labs EBIT per Share

The EBIT per Share of Laurus Labs (LAURUSLABS.NS) as of Aug 1, 2026 is 11.59 INR. In the previous year, EBIT per Share was 7.32 INR — a change of 58.36% (higher).

EBIT per Share

11.59INR

YoY

58.36%

Last updated:

EBIT per Share of Laurus Labs is 2026 11.59 INR. EBIT per Share of Laurus Labs was 2025 7.32 INR. It decreases by 58.36% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Laurus Labs Stock analysis

What does Laurus Labs do? Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Since its establishment in 2005, the company has become one of the leading providers of API products on the global market. Answer: Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Laurus Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laurus Labs stock

EBIT per Share of Laurus Labs is 11.59 INR in 2026.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Laurus Labs

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Laurus Labs